Canopy Growth (CGC) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
The latest trading day saw Canopy Growth Corporation (CGC) settling at $4.57, representing a +1.11% change from its previous close.
Canopy Growth Corporation (CGC) reachead $4.64 at the closing of the latest trading day, reflecting a -1.49% change compared to its last close.
Canopy Growth (CGC) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Zacks.com users have recently been watching Canopy Growth (CGC) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
The financial markets are closely monitoring the upcoming U.S. election, as the outcome will likely have significant implications for the broader economy. Both candidates, Donald Trump and Kamala Harris, have outlined their policies, which are expected to influence investment strategies.
What's next for marijuana stock investors as the sector's recent rise in trading has people talking. Recently there has been an increase in trading that allowed some investors to take profits. Yet in true cannabis fashion, this rise in trading was short-lived. Yet it is moments like this where newfound confidence can be found when looking to invest in legal cannabis. The growth and boom of legal cannabis are still going strong and developing day by day.
Cannabis firm Canopy Growth said on Friday its CEO, David Klein, will retire at the end of the company's current fiscal year ending March 31, 2025.
Canopy Growth (CGC) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Canopy Growth NASDAQ: CGC is one of the North American players in the cannabis industry. The company's shares have seen massive fluctuations since going public in 2014 under the name Tweed Incorporated.
Tilray Brands and Canopy Growth have taken vastly different approaches in their respective growth strategies. Canopy Growth has remained laser focused on the U.S. cannabis market while Tilray has been expanding into alcohol.
A new survey from cannabis telehealth platform NuggMD says most Americans buy their marijuana legally when they can. Ten percent of cannabis buyers still mostly buy from illegal sources.